{"id":"https://openalex.org/W4292425643","doi":"https://doi.org/10.1186/s10194-022-01470-4","title":"Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials","display_name":"Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials","publication_year":2022,"publication_date":"2022-08-18","ids":{"openalex":"https://openalex.org/W4292425643","doi":"https://doi.org/10.1186/s10194-022-01470-4","pmid":"https://pubmed.ncbi.nlm.nih.gov/35978286"},"language":"en","primary_location":{"id":"doi:10.1186/s10194-022-01470-4","doi":"https://doi.org/10.1186/s10194-022-01470-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s10194-022-01470-4","pdf_url":"https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1186/s10194-022-01470-4","source":{"id":"https://openalex.org/S143427143","display_name":"The Journal of Headache and Pain","issn_l":"1129-2369","issn":["1129-2369","1129-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Headache and Pain","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1186/s10194-022-01470-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027946799","display_name":"Christian Lampl","orcid":"https://orcid.org/0000-0003-1756-1181","observed_orcids":["https://orcid.org/0000-0003-1756-1181"]},"institutions":[{"id":"https://openalex.org/I4210102590","display_name":"Convent Hospital of the Brothers of Saint John of God","ror":"https://ror.org/01fxzb657","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210102590","https://openalex.org/I4387152425"]}],"countries":["AT"],"is_corresponding":true,"raw_author_name":"Christian Lampl","raw_affiliation_strings":["Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria. Christian.Lampl@bblinz.at","Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria"],"raw_orcid":"https://orcid.org/0000-0003-1756-1181","affiliations":[{"raw_affiliation_string":"Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria. Christian.Lampl@bblinz.at","institution_ids":["https://openalex.org/I4210102590"]},{"raw_affiliation_string":"Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria","institution_ids":["https://openalex.org/I4210102590"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Viktoria Kraus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102590","display_name":"Convent Hospital of the Brothers of Saint John of God","ror":"https://ror.org/01fxzb657","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210102590","https://openalex.org/I4387152425"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Viktoria Kraus","raw_affiliation_strings":["Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria","institution_ids":["https://openalex.org/I4210102590"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022157165","display_name":"Katrina Lehner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102590","display_name":"Convent Hospital of the Brothers of Saint John of God","ror":"https://ror.org/01fxzb657","country_code":"AT","type":"healthcare","lineage":["https://openalex.org/I4210102590","https://openalex.org/I4387152425"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Katrina Lehner","raw_affiliation_strings":["Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Konventhospital Barmherzige Br\u00fcder Linz, Seilerst\u00e4tte 2, 4020, Linz, Austria","institution_ids":["https://openalex.org/I4210102590"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065938140","display_name":"Brett Loop","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brett Loop","raw_affiliation_strings":["Novartis Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074869235","display_name":"Mahan Chehrenama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mahan Chehrenama","raw_affiliation_strings":["Amgen Inc, Thousand Oaks, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amgen Inc, Thousand Oaks, CA, USA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013806104","display_name":"Zofia M\u0105czy\u0144ska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Zofia Maczynska","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017609523","display_name":"Shannon Ritter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shannon Ritter","raw_affiliation_strings":["Novartis Pharmaceutical Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceutical Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103282311","display_name":"Jan Klatt","orcid":"https://orcid.org/0000-0002-2276-4701","observed_orcids":["https://orcid.org/0000-0002-2276-4701"]},"institutions":[{"id":"https://openalex.org/I164928964","display_name":"Merck KGaA, Darmstadt (Germany)","ror":"https://ror.org/04b2dty93","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964"]},{"id":"https://openalex.org/I4405266695","display_name":"Merck Healthcare KGaA, Darmstadt (Germany)","ror":"https://ror.org/04vpzfb52","country_code":"DE","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Klatt","raw_affiliation_strings":["Merck KgaA, Darmstadt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck KgaA, Darmstadt, Germany","institution_ids":["https://openalex.org/I164928964","https://openalex.org/I4405266695"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017296870","display_name":"Josefin Snellman","orcid":"https://orcid.org/0009-0003-6634-3823","observed_orcids":["https://orcid.org/0009-0003-6634-3823"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Josefin Snellman","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5027946799"],"corresponding_institution_ids":["https://openalex.org/I4210102590"],"apc_list":{"value":3190,"currency":"USD","value_usd":3190},"apc_paid":{"value":3190,"currency":"USD","value_usd":3190},"fwci":2.7697,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.91418438,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"23","issue":"1","first_page":"104","last_page":"104"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erenumab","display_name":"erenumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/migraine-prevention","display_name":"migraine prophylaxis","score":0.8999999761581421},{"id":"https://openalex.org/keywords/episodic-migraine","display_name":"episodic migraine","score":0.925000011920929},{"id":"https://openalex.org/keywords/chronic-migraine","display_name":"chronic migraine","score":1.0},{"id":"https://openalex.org/keywords/calcitonin-gene-related-peptide-receptor","display_name":"calcitonin gene-related peptide receptor","score":0.9039999842643738},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7609999775886536},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9620000123977661},{"id":"https://openalex.org/keywords/age-stratified-analysis","display_name":"age-stratified analysis","score":0.7379999756813049},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.906000018119812},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.875},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.9850000143051147},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.7409999966621399},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.38999998569488525},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.39100000262260437},{"id":"https://openalex.org/keywords/migraine-comorbidity","display_name":"migraine comorbidity","score":0.44600000977516174},{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/age-related-physiological-changes","display_name":"age-related physiological changes","score":0.8199999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9093738794326782},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.707487165927887},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6834603548049927},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.6745816469192505},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.586275577545166},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5209792256355286},{"id":"https://openalex.org/C2910587157","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Chronic Migraine","level":3,"score":0.5063592195510864},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4777328670024872},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4385470747947693},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.20421728491783142},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077221","descriptor_name":"Calcitonin Gene-Related Peptide Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077221","descriptor_name":"Calcitonin Gene-Related Peptide Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077221","descriptor_name":"Calcitonin Gene-Related Peptide Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077221","descriptor_name":"Calcitonin Gene-Related Peptide Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077221","descriptor_name":"Calcitonin Gene-Related Peptide Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018015","descriptor_name":"Receptors, Calcitonin Gene-Related Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018015","descriptor_name":"Receptors, Calcitonin Gene-Related Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018015","descriptor_name":"Receptors, Calcitonin Gene-Related Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018015","descriptor_name":"Receptors, Calcitonin Gene-Related Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018015","descriptor_name":"Receptors, Calcitonin Gene-Related Peptide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s10194-022-01470-4","doi":"https://doi.org/10.1186/s10194-022-01470-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s10194-022-01470-4","pdf_url":"https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1186/s10194-022-01470-4","source":{"id":"https://openalex.org/S143427143","display_name":"The Journal of Headache and Pain","issn_l":"1129-2369","issn":["1129-2369","1129-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Headache and Pain","raw_type":"journal-article"},{"id":"pmid:35978286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35978286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of headache and pain","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9386939","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9386939","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Headache Pain","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:56e680e71ca34785b385d22b45060253","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/56e680e71ca34785b385d22b45060253","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Journal of Headache and Pain, Vol 23, Iss 1, Pp 1-19 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s10194-022-01470-4","doi":"https://doi.org/10.1186/s10194-022-01470-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s10194-022-01470-4","pdf_url":"https://thejournalofheadacheandpain.biomedcentral.com/counter/pdf/10.1186/s10194-022-01470-4","source":{"id":"https://openalex.org/S143427143","display_name":"The Journal of Headache and Pain","issn_l":"1129-2369","issn":["1129-2369","1129-2377"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Headache and Pain","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8100000023841858,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4292425643.pdf","grobid_xml":"https://content.openalex.org/works/W4292425643.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W2001650386","https://openalex.org/W2004916007","https://openalex.org/W2018037264","https://openalex.org/W2031838887","https://openalex.org/W2052258972","https://openalex.org/W2119392068","https://openalex.org/W2146270980","https://openalex.org/W2283260670","https://openalex.org/W2326789314","https://openalex.org/W2608751463","https://openalex.org/W2751884637","https://openalex.org/W2770965214","https://openalex.org/W2792811290","https://openalex.org/W2811448052","https://openalex.org/W2895868360","https://openalex.org/W2898072840","https://openalex.org/W2909341932","https://openalex.org/W2937977035","https://openalex.org/W2984274085","https://openalex.org/W2986649407","https://openalex.org/W2994814664","https://openalex.org/W3109562583","https://openalex.org/W3120635632","https://openalex.org/W3130497948","https://openalex.org/W3139841107","https://openalex.org/W3150487324","https://openalex.org/W3176839476","https://openalex.org/W3200164384","https://openalex.org/W3215727333","https://openalex.org/W4214899093","https://openalex.org/W4223461132","https://openalex.org/W4281631629"],"related_works":["https://openalex.org/W2792428998","https://openalex.org/W2167297145","https://openalex.org/W1995699180","https://openalex.org/W2088263282","https://openalex.org/W3111709648","https://openalex.org/W2184178745","https://openalex.org/W4224234068","https://openalex.org/W2968888063","https://openalex.org/W4386825598","https://openalex.org/W4389449769"],"abstract_inverted_index":{"BACKGROUND:":[0],"Erenumab,":[1],"a":[2,321],"fully":[3],"human":[4],"monoclonal":[5],"antibody":[6],"that":[7],"targets":[8],"the":[9,20,34,61,82,107,182],"calcitonin":[10],"gene-related":[11],"peptide":[12],"receptor,":[13],"has":[14],"demonstrated":[15],"efficacy":[16],"and":[17,24,48,75,94,117,143,184,200,214,239,269,277,292,358],"safety":[18,35,62,79,124,134,323],"in":[19,38,41,70,99,303,331,351],"prevention":[21],"of":[22,36,43,55,63,78,88,97,125,209,220,232,264,342],"episodic":[23,102,334],"chronic":[25,104,336],"migraine.":[26],"There":[27],"exists":[28],"an":[29],"unmet":[30],"need":[31],"to":[32,146,159,190,345],"establish":[33],"erenumab":[37,64,98,126,166,173,211,215,233],"older":[39,71,352],"individuals,":[40],"view":[42],"existing":[44],"multiple":[45,355],"comorbidities,":[46,356],"polypharmacy,":[47,357],"age-related":[49,359],"physiological":[50,360],"changes.":[51,361],"This":[52],"pooled":[53],"analysis":[54,77],"five":[56,89,155],"large":[57],"migraine-prevention":[58],"studies":[59,96,156],"examined":[60],"stratified":[65,270],"across":[66,106,127,154,225,328],"age":[67,108,128,227,272,329],"groups,":[68],"particularly":[69],"populations.":[72],"METHODS:":[73],"Pooled":[74],"age-stratified":[76],"data":[80],"from":[81],"12-week":[83],"double-blind":[84],"treatment":[85],"phase":[86],"(DBTP)":[87],"randomized,":[90],"placebo-controlled":[91],"Phase":[92],"2":[93],"3":[95],"participants":[100,153,203,304,353],"with":[101,298,326,333,338,354],"or":[103,172,236,317,335],"migraine":[105],"groups":[109,129,228,273,330],"<":[110],"40":[111,242,282],"years,":[112,114,116,243,248,253,259,283,288,294],"40-49":[113,247,287],"50-59":[115,252,293],"\u2265":[118,257,306],"60":[119,258,307],"years":[120],"was":[121,130,223,279,348],"completed.":[122],"The":[123],"determined":[131],"by":[132,271],"assessing":[133],"endpoints":[135],"including":[136],"treatment-emergent":[137,221,265],"adverse":[138],"events":[139,144,343],"(AEs),":[140],"serious":[141,266,300],"AEs,":[142],"leading":[145],"study":[147],"drug":[148],"discontinuation.":[149],"RESULTS:":[150],"Overall,":[151,195],"3345":[152],"were":[157,311],"randomized":[158],"receive":[160],"either":[161],"placebo":[162,240,278,327],"(n":[163,169,176],"=":[164,170,177],"1359),":[165],"70":[167,212],"mg":[168,175,235,316],"1132)":[171],"140":[174,216,237,318],"854);":[178],"3176":[179],"(94.9%)":[180],"completed":[181],"DBTP,":[183],"169":[185],"(5.1%)":[186],"discontinued,":[187],"mainly":[188],"due":[189,344],"participant":[191],"decision":[192],"(110;":[193],"3.3%).":[194],"1349":[196],"(40.6%),":[197],"1122":[198],"(33.8%),":[199],"850":[201],"(25.6%)":[202],"received":[204],"at":[205],"least":[206],"one":[207],"dose":[208],"placebo,":[210],"mg,":[213,217],"respectively.":[218],"Incidence":[219,263],"AEs":[222,267,301],"similar":[224,322],"all":[226],"for":[229,274],"both":[230,275],"doses":[231,276],"(70":[234,315],"mg)":[238,319],"(<":[241,281],"44.0%":[244],"vs":[245,250,255,261,285,290,296],"44.4%;":[246],"42.5%":[249],"49.2%;":[251],"46.5%":[254],"41.6%;":[256],"43.8%":[260],"59.4%).":[262],"overall,":[268],"low":[280],"0.9%":[284],"1.2%;":[286],"1.7%":[289],"1.9%;":[291],"1.6%":[295],"1.1%),":[297],"no":[299,339],"reported":[302],"aged":[305],"years.":[308],"No":[309],"deaths":[310],"reported.":[312],"CONCLUSIONS:":[313],"Erenumab":[314,347],"exhibited":[320],"profile":[324],"compared":[325],"individuals":[332],"migraine,":[337],"increased":[340],"emergence":[341],"age.":[346],"well":[349],"tolerated":[350],"TRIAL":[362],"REGISTRATION":[363],"NUMBER:":[364],"ClinicalTrials.gov":[365],"Identifiers:":[366],"NCT02066415,":[367],"NCT02456740,":[368],"NCT02483585,":[369],"NCT03096834,":[370],"NCT03333109.":[371]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}